# Greg Baker

> Greg Baker is a seed investor at Alumni Ventures backing Health Care. See 86 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Fund: [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group)
- Location: Chicago, United States
- Total investments: 86
- Last investment: Jan 2026
- Lead investor: 3%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/gregebaker/
- X (Twitter): https://twitter.com/badgerforward?lang=en

Greg Baker is a seed investor at Alumni Ventures in Chicago focused on Health Care and Software. Greg is a highly accomplished executive with experience in corporate leadership, business development, startups, M&A, strategic planning, and more. He has spent much of his career growing business in the electrical products, packaging, and chemical industries. Throughout, he has been buying, selling, and combining companies to fit strategicgoals. Previously, Greg served as President and CEO of 2D2C, developing safer energy-saving products. Greg was also VP Corporate Development and Acting Division President for a high-tech subsidiary at Woodhead Industries and Director Corporate Development for Tenneco. Greg has a BS in Mechanical Engineering from the University of Wisconsin (’86) and an MBA from the Fuqua School of Business, Duke University.

## Contacts

5 contacts available for Greg Baker: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/greg-baker-2?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 19 | 22% |
| Software | 18 | 21% |
| Artificial Intelligence | 13 | 15% |
| FinTech | 7 | 8% |
| Biotechnology | 7 | 8% |

126 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 30 | 35% |
| Series A | 17 | 20% |
| Series B | 9 | 10% |
| Venture - Series Unknown | 8 | 9% |
| Series C | 7 | 8% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 65 | 76% |
| United Kingdom | 3 | 3% |
| Canada | 2 | 2% |
| Israel | 1 | 1% |
| United Arab Emirates | 1 | 1% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Juvena Therapeutics | Juvena Therapeutics is a venture-backed biopharma startup discovering novel protein-based therapeutics that promote tissue regeneration in the elderly and treat various age-related diseases. | $33.5M | Series B | Jan 12, 2026 | https://www.juvenatherapeutics.com/ |
| PortfolioPilot | PortfolioPilot is founded by a successfully exited, ex-Bridgewater team using AI + Finance expertise to build a full-stack solution for investing insights and financial advice on top of its proprietary Economic Insights Engine. They power fintech solutions available to millions of people through the API and customized insights. The flagship productis PortfolioPilot.com for individuals, your personal AI financial advisor, with over $30B assets on platform. | $2M | Seed | Sep 01, 2025 | http://www.portfoliopilot.com |
| Trajektory | Trajektory is a data insights and valuation technology with advanced demographics and proprietary valuation methodology. It provides stress-free data management that visualizes, assesses, and values the partnership data in real time. The company was founded in 2020 and is headquartered in Chicago, Illinois. |  | Series A | Jul 28, 2025 | https://www.trajektory.com |
| Enact | ENACT's Cloud platform is transforming how distributed energy resources are deployed and managed. ENACT ENVISION is used by providers to remotely design complete solar rooftop and storage solutions, as well as finalize contracts and track execution. ENACT ENGAGE is used by end-customers to track financial savings and energy usage and predicttheir future outcomes. The powerful two-sided platform leverages powerful data analytics to improve customer experience and outcomes. | $2.1M | Series A | Jul 17, 2025 | http://www.enact-systems.com/ |
| Ubicept | Ubicept is a computer vision company. They provide machine learning services by combining next-generation image sensors with computer vision algorithms. Their products include photon-counting cameras, edge photon processing, and a private developer portal. | $4.6M | Venture - Series Unknown | Jun 24, 2025 | https://www.ubicept.com/ |
| Ruby Bio | Ruby Bio is a biosynthesis platform that can manufacture complex molecules that are biodegradable and non-toxic. Ruby Bio uses naturally occurring yeast as a factory to convert low-cost sugar into high-value products. | $8M | Seed | Jun 09, 2025 | https://www.rubybio.com/ |
| Realta Fusion | Realta Fusion develops fusion energy technology for the production of industrial heat and power. It applies advances in super-conducting materials, plasma physics, and computing power to a simple linear fusion reactor configuration. It utilizes abundant fuel sources to provide a zero-carbon source of heat and power. | $36M | Series A | May 13, 2025 | https://realtafusion.com/ |
| Kyte | A B2B solution providing full functionality to access airline API’s, for both NDC and Low cost carriers. | $3.3M | Seed | Mar 14, 2025 | https://www.gokyte.com/ |
| Closure | Closure enables police, prosecutors, attorneys, and investigators to swiftly uncover the truth. | $7M | Seed | Mar 12, 2025 | https://closure-intel.com/ |
| SHINE Technologies | SHINE Medical Technologies, Inc. manufactures and supplies medical tracers and cancer treatment elements. The company offers Molybdenum-99, a light-emitting element that is administered to patients for the purpose of diagnosing and staging cancer and heart diseases. It also provides Iodine-131 that is used to treat thyroid cancer and variousabnormal thyroid conditions, including hyperthyroidism, as well as to diagnose liver function, renal blood flow, and urinary tract obstruction.The company was founded in 2010 and is headquartered in Janesville, Wisconsin. |  | Series C | Feb 24, 2025 | https://www.shinemed.com |

10 of 86 investments shown.

## Co-investors
- [Blue Ivy Ventures](https://shizune.co/investors/profile/blue-ivy-ventures) — VC Fund, 4 deals together
- [Brightstone Venture Capital](https://shizune.co/investors/profile/brightstone-venture-capital) — VC Fund, 3 deals together
- [CloudScale Capital Partners](https://shizune.co/investors/profile/cloudscale-capital-partners) — VC Fund, 3 deals together
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund, 3 deals together
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 3 deals together
- [Parkway Venture Capital](https://shizune.co/investors/profile/parkway-venture-capital) — VC Fund, 3 deals together

## About Alumni Ventures

VC Fund · Manchester, United States

Alumni Ventures identifies and co-invests in deals alongside various established venture capital firms across multiple stages, from pre-seed to later-stage growth. Investors can participate through annual funds containing multiple companies or via a syndicate for individual deal-by-deal selections. The firm maintains several distinct investmentteams that evaluate opportunities across sectors such as artificial intelligence, healthcare, and strategic technology.

5 contacts available at Alumni Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Aaron Sandford | Graphic Designer | https://shizune.co/investors/profile/aaron-sandford |
| Alea Capello | 'People and Culture, Associate | https://shizune.co/investors/profile/alea-capello-alea-capello-64e1 |
| Alexandra Critch | Product Manager Lead MarTec | https://shizune.co/investors/profile/alexandra-critch |
| Alex Ovabor | VenturesCorps Analyst | https://shizune.co/investors/profile/alex-ovabor |
| Allison Newman | Paralegal, Compliance Officer | https://shizune.co/investors/profile/allison-newman |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

## FAQ

### What does Greg Baker invest in?

Greg Baker invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 86 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Greg Baker?

Public channels for Greg Baker include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Greg Baker last invest?

The most recent investment recorded for Greg Baker closed in Jan 2026. Shizune tracks 86 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co